Stay updated on Dapagliflozin-Induced Liver Injury Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin-Induced Liver Injury Clinical Trial page.

Latest updates to the Dapagliflozin-Induced Liver Injury Clinical Trial page
- Check5 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, indicating a newer version of the page.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedFooter version updated from v3.6.4 to v3.6.5, indicating a minor platform update with no changes to study information.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3, indicating a site-wide software update. This appears to be a backend release that does not modify the study details or displayed content.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.6.3 replaces v3.6.2 on the page header, signaling a small update to the published page without changing the study information.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page's revision tag updated from v3.6.0 to v3.6.2, indicating a backend or UI update with no visible changes to the study information.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page now shows that the study is no longer recruiting participants, clarifying enrollment status. New help sections such as 'How to Read a Study Record,' 'Common Questions,' and 'How to Join a Study' were added to guide users.SummaryDifference0.5%

Stay in the know with updates to Dapagliflozin-Induced Liver Injury Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin-Induced Liver Injury Clinical Trial page.